Other Species / Isoforms
  MASTL (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K9-ub
DPTAGSKkEPGGGAA
0 1
MASTL (human) DPTAGSKkEPGGGAA K9-ub
MASTL iso2 (human) DPTAGSKKEPGGGAA K9
MASTL (mouse) MESASASEENEGGAA E8
MASTL (rat) MESASGSEENEEGAA E8
S31-p
IAVPKPPsIEEFSIV
0 1
MASTL (human) IAVPKPPsIEEFSIV S31-p
MASTL iso2 (human) IAVPKPPSIEEFSIV S31
MASTL (mouse) IPVPRPPSIEEFTIV S30
MASTL (rat) IPVPRPPSIEEFTIV S30
K39-ub
IEEFSIVkPISRGAF
0 4
MASTL (human) IEEFSIVkPISRGAF K39-ub
MASTL iso2 (human) IEEFSIVKPISRGAF K39
MASTL (mouse) IEEFTIVKPISRGAF K38
MASTL (rat) IEEFTIVKPISRGAF K38
K48-ub
ISRGAFGkVYLGQkG
0 1
MASTL (human) ISRGAFGkVYLGQkG K48-ub
MASTL iso2 (human) ISRGAFGKVYLGQKG K48
MASTL (mouse) ISRGAFGKVYLGQKG K47
MASTL (rat) ISRGAFGKVYLGQKG K47
K54-ub
GkVYLGQkGGkLYAV
0 1
MASTL (human) GkVYLGQkGGkLYAV K54-ub
MASTL iso2 (human) GKVYLGQKGGKLYAV K54
MASTL (mouse) GKVYLGQKGGKLYAV K53
MASTL (rat) GKVYLGQKGSKLYAV K53
K57-ub
YLGQkGGkLYAVkVV
0 2
MASTL (human) YLGQkGGkLYAVkVV K57-ub
MASTL iso2 (human) YLGQKGGKLYAVKVV K57
MASTL (mouse) YLGQKGGKLYAVKVV K56
MASTL (rat) YLGQKGSKLYAVKVV K56
K62-ub
GGkLYAVkVVKkADM
0 1
MASTL (human) GGkLYAVkVVKkADM K62-ub
MASTL iso2 (human) GGKLYAVKVVKKADM K62
MASTL (mouse) GGKLYAVKVVKKADM K61
MASTL (rat) GSKLYAVKVVKKADM K61
K66-ub
YAVkVVKkADMINkN
0 1
MASTL (human) YAVkVVKkADMINkN K66-ub
MASTL iso2 (human) YAVKVVKKADMINKN K66
MASTL (mouse) YAVKVVKKADMINKN K65
MASTL (rat) YAVKVVKKADMINKN K65
K72-ub
KkADMINkNMtHQVQ
0 1
MASTL (human) KkADMINkNMtHQVQ K72-ub
MASTL iso2 (human) KKADMINKNMTHQVQ K72
MASTL (mouse) KKADMINKNMTHQVQ K71
MASTL (rat) KKADMINKNMTHQVQ K71
T75-p
DMINkNMtHQVQAER
Upstream
0 1
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) DMINkNMtHQVQAER T75-p
MASTL iso2 (human) DMINKNMTHQVQAER T75
MASTL (mouse) DMINKNMTHQVQAER T74
MASTL (rat) DMINKNMTHQVQAER T74
K158-ub
GIIHRDLkPDNMLIS
0 1
MASTL (human) GIIHRDLkPDNMLIS K158-ub
MASTL iso2 (human) GIIHRDLKPDNMLIS K158
MASTL (mouse) GIIHRDLKPDNMLIS K157
MASTL (rat) GIIHRDLKPDNMLIS K157
S178-p
KLTDFGLskVTLNRD
0 2
MASTL (human) KLTDFGLskVTLNRD S178-p
MASTL iso2 (human) KLTDFGLSKVTLNRD S178
MASTL (mouse) KLTDFGLsKVTLNRD S177-p
MASTL (rat) KLTDFGLSKVTLNRD S177
K179-ub
LTDFGLskVTLNRDI
0 4
MASTL (human) LTDFGLskVTLNRDI K179-ub
MASTL iso2 (human) LTDFGLSKVTLNRDI K179
MASTL (mouse) LTDFGLsKVTLNRDI K178
MASTL (rat) LTDFGLSKVTLNRDI K178
T194-p
NMMDILTtPSMAkPR
Upstream
Downstream
2 3
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK2 (human)
Putative in vivo kinases:
  • CDK1 (human)
Putative upstream phosphatases:
  • PPP2R2A (human)
  • PPP2R2D (human)
Regulatory protein:
  • CTDP1 (human)
Treatment
  • 1NM-PP1
  • calyculin_A
  • okadaic_acid
  • RO-3306
  • siRNA
  • tautomycin
MASTL (human) NMMDILTtPSMAkPR T194-p
MASTL iso2 (human) NMMDILTTPSMAKPR T194
MASTL (mouse) NMMDILTtPSMSKPK T193-p
MASTL (rat) NMMDILTTPSMSKPK T193
K199-ub
LTtPSMAkPRQDYSR
0 4
MASTL (human) LTtPSMAkPRQDYSR K199-ub
MASTL iso2 (human) LTTPSMAKPRQDYSR K199
MASTL (mouse) LTtPSMSKPKQDYSR K198
MASTL (rat) LTTPSMSKPKQDYSR K198
T207-p
PRQDYSRtPGQVLSL
Upstream
1 2
Treatment
  • nocodazole
MASTL (human) PRQDYSRtPGQVLSL T207-p
MASTL iso2 (human) PRQDYSRTPGQVLSL T207
MASTL (mouse) PKQDYSRtPGQVLSL T206-p
MASTL (rat) PKQDYSRTPGQVLSL T206
S216-p
GQVLSLIssLGFNtP
0 1
MASTL (human) GQVLSLIssLGFNtP S216-p
MASTL iso2 (human) GQVLSLISSLGFNTP S216
MASTL (mouse) GQVLSLISSLGFFTP S215
MASTL (rat) GQVLSLISSLGFFTP S215
S217-p
QVLSLIssLGFNtPI
Upstream
0 1
Treatment
  • nocodazole
MASTL (human) QVLSLIssLGFNtPI S217-p
MASTL iso2 (human) QVLSLISSLGFNTPI S217
MASTL (mouse) QVLSLISSLGFFTPV S216
MASTL (rat) QVLSLISSLGFFTPV S216
T222-p
IssLGFNtPIAEKNQ
Upstream
0 4
Treatment
  • nocodazole
MASTL (human) IssLGFNtPIAEKNQ T222-p
MASTL iso2 (human) ISSLGFNTPIAEKNQ T222
MASTL (mouse) ISSLGFFTPVGEKDQ T221
MASTL (rat) ISSLGFFTPVGEKDQ T221
K258-sm
CPMSVDQkDTtPYss
0 1
MASTL (human) CPMSVDQkDTtPYss K258-sm
MASTL iso2 (human) CPMSVDQKDTTPYSS K258
MASTL (mouse) CPMSVDQKEPTSYSS K256
MASTL (rat) CPMSIDQKEPISYSS K256
T261-p
SVDQkDTtPYsskLL
0 1
MASTL (human) SVDQkDTtPYsskLL T261-p
MASTL iso2 (human) SVDQKDTTPYSSKLL T261
MASTL (mouse) SVDQKEPTSYSSKLL T259
MASTL (rat) SIDQKEPISYSSKLL I259
S264-p
QkDTtPYsskLLksC
0 2
MASTL (human) QkDTtPYsskLLksC S264-p
MASTL iso2 (human) QKDTTPYSSKLLKSC S264
MASTL (mouse) QKEPTSYSSKLLKSC S262
MASTL (rat) QKEPISYSSKLLKSC S262
S265-p
kDTtPYsskLLksCL
0 1
MASTL (human) kDTtPYsskLLksCL S265-p
MASTL iso2 (human) KDTTPYSSKLLKSCL S265
MASTL (mouse) KEPTSYSSKLLKSCF S263
MASTL (rat) KEPISYSSKLLKSCF S263
K266-ub
DTtPYsskLLksCLE
0 1
MASTL (human) DTtPYsskLLksCLE K266-ub
MASTL iso2 (human) DTTPYSSKLLKSCLE K266
MASTL (mouse) EPTSYSSKLLKSCFE K264
MASTL (rat) EPISYSSKLLKSCFE K264
K269-ub
PYsskLLksCLEtVA
0 3
MASTL (human) PYsskLLksCLEtVA K269-ub
MASTL iso2 (human) PYSSKLLKSCLETVA K269
MASTL (mouse) SYSSKLLKSCFETLS K267
MASTL (rat) SYSSKLLKSCFETLA K267
K269-m1
PYsskLLksCLEtVA
0 1
MASTL (human) PYsskLLksCLEtVA K269-m1
MASTL iso2 (human) PYSSKLLKSCLETVA K269
MASTL (mouse) SYSSKLLKSCFETLS K267
MASTL (rat) SYSSKLLKSCFETLA K267
S270-p
YsskLLksCLEtVAs
Upstream
0 1
Treatment
  • BI2536
MASTL (human) YsskLLksCLEtVAs S270-p
MASTL iso2 (human) YSSKLLKSCLETVAS S270
MASTL (mouse) YSSKLLKSCFETLSS S268
MASTL (rat) YSSKLLKSCFETLAS S268
T274-p
LLksCLEtVAsNPGM
Upstream
0 1
Treatment
  • MLN8054
MASTL (human) LLksCLEtVAsNPGM T274-p
MASTL iso2 (human) LLKSCLETVASNPGM T274
MASTL (mouse) LLKSCFETLSSNPEI T272
MASTL (rat) LLKSCFETLASNPEI T272
S277-p
sCLEtVAsNPGMPVk
Upstream
0 5
Treatment
  • AZD1152
  • BI2536
  • ZM447439
MASTL (human) sCLEtVAsNPGMPVk S277-p
MASTL iso2 (human) SCLETVASNPGMPVK S277
MASTL (mouse) SCFETLSSNPEIPVK S275
MASTL (rat) SCFETLASNPEIPVK S275
K284-ub
sNPGMPVkCLTsNLL
0 2
MASTL (human) sNPGMPVkCLTsNLL K284-ub
MASTL iso2 (human) SNPGMPVKCLTSNLL K284
MASTL (mouse) SNPEIPVKCLTSNLL K282
MASTL (rat) SNPEIPVKCLTSNLL K282
S288-p
MPVkCLTsNLLQsRK
0 1
MASTL (human) MPVkCLTsNLLQsRK S288-p
MASTL iso2 (human) MPVKCLTSNLLQSRK S288
MASTL (mouse) IPVKCLTSNLLQCRK S286
MASTL (rat) IPVKCLTSNLLQCRK S286
S293-p
LTsNLLQsRKRLAtS
0 5
MASTL (human) LTsNLLQsRKRLAtS S293-p
MASTL iso2 (human) LTSNLLQSRKRLATS S293
MASTL (mouse) LTSNLLQCRKRLGtS C291
MASTL (rat) LTSNLLQCRKRLGTS C291
T299-p
QsRKRLAtSSAsSQS
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
  • protein degradation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell cycle regulation
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • LY294002
MASTL (human) QsRKRLAtSSAsSQS T299-p
MASTL iso2 (human) QSRKRLATSSASSQS T299
MASTL (mouse) QCRKRLGtSSTSSQS T297-p
MASTL (rat) QCRKRLGTSSTSSQS T297
S303-p
RLAtSSAsSQSHTFI
0 1
MASTL (human) RLAtSSAsSQSHTFI S303-p
MASTL iso2 (human) RLATSSASSQSHTFI S303
MASTL (mouse) RLGtSSTSSQSHTFV S301
MASTL (rat) RLGTSSTSSQSHTFV S301
S311-p
SQSHTFIsSVESECH
0 1
MASTL (human) SQSHTFIsSVESECH S311-p
MASTL iso2 (human) SQSHTFISSVESECH S311
MASTL (mouse) SQSHTFVSSVESECH S309
MASTL (rat) SQSHTFVSSVESECH S309
S319-p
SVESECHssPkWEKD
0 1
MASTL (human) SVESECHssPkWEKD S319-p
MASTL iso2 (human) SVESECHSSPKWEKD S319
MASTL (mouse) SVESECHSNPKWERD S317
MASTL (rat) SVESECHSSPKWEKD S317
S320-p
VESECHssPkWEKDC
0 2
MASTL (human) VESECHssPkWEKDC S320-p
MASTL iso2 (human) VESECHSSPKWEKDC S320
MASTL (mouse) VESECHSNPKWERDC N318
MASTL (rat) VESECHSSPKWEKDC S318
K322-ub
SECHssPkWEKDCQE
0 1
MASTL (human) SECHssPkWEKDCQE K322-ub
MASTL iso2 (human) SECHSSPKWEKDCQE K322
MASTL (mouse) SECHSNPKWERDCQS K320
MASTL (rat) SECHSSPKWEKDCQS K320
S330-p
WEKDCQEsDEALGPT
0 2
MASTL (human) WEKDCQEsDEALGPT S330-p
MASTL iso2 (human) WEKDCQESDEALGPT S330
MASTL (mouse) KWERDCQSTESSGCA S327
MASTL (rat) WEKDCQSAKPSSTMM A328
K350-ub
AVEKLCAkSANAIET
0 4
MASTL (human) AVEKLCAkSANAIET K350-ub
MASTL iso2 (human) AVEKLCAKSANAIET K350
MASTL (mouse) AVEMLYAKSTsAIKT K346
MASTL (rat) AGEMPYAKSVSAIET K346
N353
KLCAkSANAIETkGF
0 1
MASTL (human) KLCAkSANAIETkGF N353
MASTL iso2 (human) KLCAKSANAIETKGF N353
MASTL (mouse) MLYAKSTsAIKTKtE S349-p
MASTL (rat) MPYAKSVSAIETKTD S349
K358-ub
SANAIETkGFNKkDL
0 1
MASTL (human) SANAIETkGFNKkDL K358-ub
MASTL iso2 (human) SANAIETKGFNKKDL K358
MASTL (mouse) gap -
MASTL (rat) gap -
K363
ETkGFNKKDLELALs
0 1
MASTL (human) ETkGFNKKDLELALs K363
MASTL iso2 (human) ETKGFNKKDLELALS K363
MASTL (mouse) TsAIKTKtELELALs T355-p
MASTL (rat) VSAIETKTDLELALS T355
K363-ub
ETkGFNKkDLELALs
0 1
MASTL (human) ETkGFNKkDLELALs K363-ub
MASTL iso2 (human) ETKGFNKKDLELALS K363
MASTL (mouse) TsAIKTKTELELALs T355
MASTL (rat) VSAIETKTDLELALS T355
S370-p
kDLELALsPIHNssA
Upstream
0 24
Treatment
  • metastatic potential
  • nocodazole
MASTL (human) kDLELALsPIHNssA S370-p
MASTL iso2 (human) KDLELALSPIHNSSA S370
MASTL (mouse) tELELALsPIHDSsA S362-p
MASTL (rat) TDLELALSPIHDSSN S362
S375-p
ALsPIHNssALPtTG
0 2
MASTL (human) ALsPIHNssALPtTG S375-p
MASTL iso2 (human) ALSPIHNSSALPTTG S375
MASTL (mouse) ALsPIHDSsAIPAAG S367
MASTL (rat) ALSPIHDSSNIPPTG S367
S376-p
LsPIHNssALPtTGR
0 2
MASTL (human) LsPIHNssALPtTGR S376-p
MASTL iso2 (human) LSPIHNSSALPTTGR S376
MASTL (mouse) LsPIHDSsAIPAAGS S368-p
MASTL (rat) LSPIHDSSNIPPTGR S368
T380-p
HNssALPtTGRsCVN
0 1
MASTL (human) HNssALPtTGRsCVN T380-p
MASTL iso2 (human) HNSSALPTTGRSCVN T380
MASTL (mouse) HDSsAIPAAGSNQVT A372
MASTL (rat) HDSSNIPPTGRNYMT P372
S384-p
ALPtTGRsCVNLAkK
0 2
MASTL (human) ALPtTGRsCVNLAkK S384-p
MASTL iso2 (human) ALPTTGRSCVNLAKK S384
MASTL (mouse) AIPAAGSNQVTLPRK N376
MASTL (rat) NIPPTGRNYMTLPRK N376
K390-ub
RsCVNLAkKCFSGEV
0 1
MASTL (human) RsCVNLAkKCFSGEV K390-ub
MASTL iso2 (human) RSCVNLAKKCFSGEV K390
MASTL (mouse) SNQVTLPRKCFREIs R382
MASTL (rat) RNYMTLPRKCFSREI R382
S398
KCFSGEVSWEAVELD
0 2
MASTL (human) KCFSGEVSWEAVELD S398
MASTL iso2 (human) KCFSGEVSWEAVELD S398
MASTL (mouse) RKCFREIsWEARDPD S389-p
MASTL (rat) KCFSREIsWEAREPD S390-p
S442-p
EEHLGKRsLKRNFEL
0 2
MASTL (human) EEHLGKRsLKRNFEL S442-p
MASTL iso2 (human) EEHLGKRSLKRNFEL S442
MASTL (mouse) EEHLGKRNYKRNFHL N431
MASTL (rat) EEHLCKRNCKRNFHL N432
S452-p
RNFELVDssPCKKII
0 6
MASTL (human) RNFELVDssPCKKII S452-p
MASTL iso2 (human) RNFELVDSSPCKKII S452
MASTL (mouse) RNFHLVDSSPCQEIM S441
MASTL (rat) RNFHLVDSSPCQEII S442
S453-p
NFELVDssPCKKIIQ
0 16
MASTL (human) NFELVDssPCKKIIQ S453-p
MASTL iso2 (human) NFELVDSSPCKKIIQ S453
MASTL (mouse) NFHLVDSSPCQEIMQ S442
MASTL (rat) NFHLVDSSPCQEIIQ S443
K497-ub
DLKLSVHkSQQNDCA
0 1
MASTL (human) DLKLSVHkSQQNDCA K497-ub
MASTL iso2 (human) DLKLSVHKSQQNDCA K497
MASTL (mouse) NLKLSGCESQQLDYA E487
MASTL (rat) NLKLSVCKSQQHDYA K488
K506-ub
QQNDCANkENIVNsF
0 1
MASTL (human) QQNDCANkENIVNsF K506-ub
MASTL iso2 (human) QQNDCANKENIVNSF K506
MASTL (mouse) QQLDYANKENIVTYL K496
MASTL (rat) QQHDYANKENTVTYL K497
S512-p
NkENIVNsFtDkQQt
Upstream
0 14
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) NkENIVNsFtDkQQt S512-p
MASTL iso2 (human) NKENIVNSFTDKQQT S512
MASTL (mouse) NKENIVTYLTDRQtP Y502
MASTL (rat) NKENTVTYLTDRRTP Y503
T514-p
ENIVNsFtDkQQtPE
0 3
MASTL (human) ENIVNsFtDkQQtPE T514-p
MASTL iso2 (human) ENIVNSFTDKQQTPE T514
MASTL (mouse) ENIVTYLTDRQtPEK T504
MASTL (rat) ENTVTYLTDRRTPEE T505
K516-ub
IVNsFtDkQQtPEKL
0 1
MASTL (human) IVNsFtDkQQtPEKL K516-ub
MASTL iso2 (human) IVNSFTDKQQTPEKL K516
MASTL (mouse) IVTYLTDRQtPEKLH R506
MASTL (rat) TVTYLTDRRTPEELH R507
T519-p
sFtDkQQtPEKLPIP
Upstream
0 10
Treatment
  • nocodazole
MASTL (human) sFtDkQQtPEKLPIP T519-p
MASTL iso2 (human) SFTDKQQTPEKLPIP T519
MASTL (mouse) TYLTDRQtPEKLHIP T508-p
MASTL (rat) TYLTDRRTPEELHIP T509
S550-p
NSKRDYLsssFLCsD
0 1
MASTL (human) NSKRDYLsssFLCsD S550-p
MASTL iso2 (human) NSKRDYLSSSFLCSD S550
MASTL (mouse) SSKKDCLSSNSVCSD S539
MASTL (rat) SSKKDCLHSNSVCSD H540
S551-p
SKRDYLsssFLCsDD
0 1
MASTL (human) SKRDYLsssFLCsDD S551-p
MASTL iso2 (human) SKRDYLSSSFLCSDD S551
MASTL (mouse) SKKDCLSSNSVCSDE S540
MASTL (rat) SKKDCLHSNSVCSDE S541
S552-p
KRDYLsssFLCsDDD
Upstream
0 4
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) KRDYLsssFLCsDDD S552-p
MASTL iso2 (human) KRDYLSSSFLCSDDD S552
MASTL (mouse) KKDCLSSNSVCSDED N541
MASTL (rat) KKDCLHSNSVCSDED N542
S556-p
LsssFLCsDDDRASK
Upstream
0 3
Treatment
  • BI2536
  • MLN8054
MASTL (human) LsssFLCsDDDRASK S556-p
MASTL iso2 (human) LSSSFLCSDDDRASK S556
MASTL (mouse) LSSNSVCSDEDRALK S545
MASTL (rat) LHSNSVCSDEDRAPK S546
S597-p
SDRSIKEssFEESNI
Upstream
0 1
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) SDRSIKEssFEESNI S597-p
MASTL iso2 (human) SDRSIKESSFEESNI S597
MASTL (mouse) PDKSIRDYSFEEPNT Y586
MASTL (rat) PDKSIRDYSFEEPNT Y587
S598-p
DRSIKEssFEESNIE
Upstream
0 1
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) DRSIKEssFEESNIE S598-p
MASTL iso2 (human) DRSIKESSFEESNIE S598
MASTL (mouse) DKSIRDYSFEEPNTE S587
MASTL (rat) DKSIRDYSFEEPNTE S588
T611-p
IEDPLIVtPDCQEKt
0 1
MASTL (human) IEDPLIVtPDCQEKt T611-p
MASTL iso2 (human) IEDPLIVTPDCQEKT T611
MASTL (mouse) NTEDLFVLPKCQENS L599
MASTL (rat) NTEDLLMLPKCQENS L600
T618-p
tPDCQEKtSPkGVEN
0 1
MASTL (human) tPDCQEKtSPkGVEN T618-p
MASTL iso2 (human) TPDCQEKTSPKGVEN T618
MASTL (mouse) LPKCQENSLPQDDCH S606
MASTL (rat) LPKCQENSLPKDDWH S607
K621-ub
CQEKtSPkGVENPAV
0 1
MASTL (human) CQEKtSPkGVENPAV K621-ub
MASTL iso2 (human) CQEKTSPKGVENPAV K621
MASTL (mouse) CQENSLPQDDCHACI Q609
MASTL (rat) CQENSLPKDDWHASI K610
S631-p
ENPAVQEsNQkMLGP
0 5
MASTL (human) ENPAVQEsNQkMLGP S631-p
MASTL iso2 (human) ENPAVQESNQKMLGP S631
MASTL (mouse) CHACIQDSSQVSAHP S619
MASTL (rat) WHASIQDSNQMLAPP S620
K634-ub
AVQEsNQkMLGPPLE
0 1
MASTL (human) AVQEsNQkMLGPPLE K634-ub
MASTL iso2 (human) AVQESNQKMLGPPLE K634
MASTL (mouse) gap -
MASTL (rat) gap -
K644-ac
GPPLEVLkTLASKRN
0 1
MASTL (human) GPPLEVLkTLASKRN K644-ac
MASTL iso2 (human) GPPLEVLKTLASKRN K644
MASTL (mouse) AHPSKAPKALTSKIN K631
MASTL (rat) APPSKAPKTFASKTN K632
K644-ub
GPPLEVLkTLASKRN
0 2
MASTL (human) GPPLEVLkTLASKRN K644-ub
MASTL iso2 (human) GPPLEVLKTLASKRN K644
MASTL (mouse) AHPSKAPKALTSKIN K631
MASTL (rat) APPSKAPKTFASKTN K632
S657-p
RNAVAFRsFNsHINA
Upstream
0 8
Treatment
  • BI2536
  • MLN8054
MASTL (human) RNAVAFRsFNsHINA S657-p
MASTL iso2 (human) RNAVAFRSFNSHINA S657
MASTL (mouse) INVVAFRSFNSHINA S644
MASTL (rat) TNVVAFRSFSSHINA S645
S660-p
VAFRsFNsHINAsNN
Upstream
0 2
Treatment
  • AZD1152
  • BI2536
  • ZM447439
MASTL (human) VAFRsFNsHINAsNN S660-p
MASTL iso2 (human) VAFRSFNSHINASNN S660
MASTL (mouse) VAFRSFNSHINASTN S647
MASTL (rat) VAFRSFSSHINASSN S648
S665-p
FNsHINAsNNsEPsR
Upstream
0 4
Treatment
  • BI2536
  • MLN8054
MASTL (human) FNsHINAsNNsEPsR S665-p
MASTL iso2 (human) FNSHINASNNSEPSR S665
MASTL (mouse) FNSHINASTNSEPSK S652
MASTL (rat) FSSHINASSNSEPSK S653
S668-p
HINAsNNsEPsRMNM
Upstream
0 5
Treatment
  • BI2536
  • MLN8054
  • nocodazole
MASTL (human) HINAsNNsEPsRMNM S668-p
MASTL iso2 (human) HINASNNSEPSRMNM S668
MASTL (mouse) HINASTNSEPSKISI S655
MASTL (rat) HINASSNSEPSKVST S656
S671-p
AsNNsEPsRMNMTSL
0 2
MASTL (human) AsNNsEPsRMNMTSL S671-p
MASTL iso2 (human) ASNNSEPSRMNMTSL S671
MASTL (mouse) ASTNSEPSKISITSL S658
MASTL (rat) ASSNSEPSKVSTTSL S659
T696-p
GSYPMAItPTQKRRS
0 1
MASTL (human) GSYPMAItPTQKRRS T696-p
MASTL iso2 (human) GSYPMAITPTQKRRs T696
MASTL (mouse) GSYPMAVSPTEKGRH S683
MASTL (rat) GSCPMAVTPTEKGRA T684
S703
tPTQKRRSCMPHQQt
0 1
MASTL (human) tPTQKRRSCMPHQQt S703
MASTL iso2 (human) TPTQKRRsCMPHQtP S703-p
MASTL (mouse) SPTEKGRHYTSHQTP H690
MASTL (rat) TPTEKGRACVSHQTP A691
T710-p
SCMPHQQtPNQIkSG
0 6
MASTL (human) SCMPHQQtPNQIkSG T710-p
MASTL iso2 (human) RsCMPHQtPNQIkSG T709-p
MASTL (mouse) RHYTSHQTPNQVKLG T696
MASTL (rat) RACVSHQTPSQVKLG T697
K715-ub
QQtPNQIkSGtPyRt
0 1
MASTL (human) QQtPNQIkSGtPyRt K715-ub
MASTL iso2 (human) HQtPNQIkSGtPYRt K714-ub
MASTL (mouse) HQTPNQVKLGTSYRT K701
MASTL (rat) HQTPSQVKLGTSYRT K702
T718-p
PNQIkSGtPyRtPKs
0 1
MASTL (human) PNQIkSGtPyRtPKs T718-p
MASTL iso2 (human) PNQIkSGtPYRtPKS T717-p
MASTL (mouse) PNQVKLGTSYRTPKS T704
MASTL (rat) PSQVKLGTSYRTPKS T705
Y720-p
QIkSGtPyRtPKsVR
0 2
MASTL (human) QIkSGtPyRtPKsVR Y720-p
MASTL iso2 (human) QIkSGtPYRtPKSVR Y719
MASTL (mouse) QVKLGTSYRTPKSVR Y706
MASTL (rat) QVKLGTSYRTPKSVR Y707
T722-p
kSGtPyRtPKsVRRG
0 4
MASTL (human) kSGtPyRtPKsVRRG T722-p
MASTL iso2 (human) kSGtPYRtPKSVRRG T721-p
MASTL (mouse) KLGTSYRTPKSVRRG T708
MASTL (rat) KLGTSYRTPKSVRRG T709
S725-p
tPyRtPKsVRRGVAP
0 3
MASTL (human) tPyRtPKsVRRGVAP S725-p
MASTL iso2 (human) tPYRtPKSVRRGVAP S724
MASTL (mouse) TSYRTPKSVRRGAAP S711
MASTL (rat) TSYRTPKSVRRGPPP S712
T741-p
DDGRILGtPDYLAPE
0 2
MASTL (human) DDGRILGtPDYLAPE T741-p
MASTL iso2 (human) DDGRILGTPDYLAPE T740
MASTL (mouse) DDGRILGTPDYLAPE T727
MASTL (rat) DDGRILGTPDYLAPE T728
T860-p
QPDDETDtSYFEARN
Upstream
Downstream
0 1
Effects on Modified Protein
  • protein conformation
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) QPDDETDtSYFEARN T860-p
MASTL iso2 (human) QPDDETDTSYFEARN T821
MASTL (mouse) QPDDETDTSYFEARN T846
MASTL (rat) QPDNETDTSYFEARN T847
T873-p
RNTAQHLtVsGFsL_
Upstream
0 1
Kinase, in vitro:
  • PLK1 (frog)
MASTL (human) RNTAQHLtVsGFsL_ T873-p
MASTL iso2 (human) RNTAQHLTVSGFSL_ T834
MASTL (mouse) RNNAQHLTIsGFSL_ T859
MASTL (rat) RNNAQHLTISGFSL_ T860
S875-p
TAQHLtVsGFsL___
Upstream
Downstream
1 9
Effects on Modified Protein
  • enzymatic activity, induced
  • phosphorylation
  • protein conformation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
  • PLK1 (frog)
MASTL (human) TAQHLtVsGFsL___ S875-p
MASTL iso2 (human) TAQHLTVSGFSL___ S836
MASTL (mouse) NAQHLTIsGFSL___ S861-p
MASTL (rat) NAQHLTISGFSL___ S862
S878-p
HLtVsGFsL______
Upstream
0 9
Treatment
  • MG132_withdrawal
MASTL (human) HLtVsGFsL______ S878-p
MASTL iso2 (human) HLTVSGFSL______ S839
MASTL (mouse) HLTIsGFSL______ S864
MASTL (rat) HLTISGFSL______ S865